Cite

    Luca Iaccarino et al.. “Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study.” Journal of autoimmunity, vol. 86, 2018, pp. 1–8. http://access.bl.uk/ark:/81055/vdc_100054806989.0x000037